Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

News & Opinion

News and Opinion from the Pandemic Sciences Institute at the University of Oxford

World's first Phase II Nipah virus vaccine trial launch

The trial will assess the safety and immune response of the ChAdOx1 NipahB vaccine, developed by PSI scientists, in a region where the virus causes recurrent outbreaks.

First volunteer receives Lassa fever vaccine in cutting-edge Oxford trial

The vaccine developed by PSI researchers aims to advance the fight against Lassa fever virus, a WHO priority pathogen posing a significant public health risk.

PSI-Dr Jenner’s House collaborative school’s programme wins educational award

The Frances Garnham Award for Education celebrates innovative approaches to educational or community engagement.

New analysis reveals major global gaps in genomic surveillance of antimicrobial resistance (AMR) – a call to action

The analysis draws on data aggregated through the amr.watch platform, created by PSI's Centre for Genomic Pathogen Surveillance to build more equitable and effective genomic surveillance worldwide.

PSI Director calls for stronger pandemic intelligence after UK Covid-19 Inquiry Module 2 report published

Professor Sir Peter Horby comments on the UK Covid-19 Inquiry Module 2 report.

Professor Alice Norton speaking into a microphone at the International Pandemic Sciences Conference

UK must step up its pandemic preparedness plans

PSI colleagues Professor Alice Norton, Professor Samantha Vanderslott and Professor Sir Peter Horby reflect on what the WHO Pandemic Agreement means for the UK, in a BMJ editorial.

Scientist working in vaccine laboratory

New research reveals optimal time intervals for COVID-19 vaccine boosters

Two new papers from University of Oxford scientists have shown how the immune system reacts differently depending on the length of interval between vaccine doses.

PSI-industry oral vaccine project aims to transform immunisation strategies

The project led by Professor Dame Sarah Gilbert is one of the winners of the first VaxHub Sustainable Platform Funding Call.

Bubonic plague treatment proven highly effective and safe in global first

Researchers from the UK and Madagascar, in collaboration with Madagascar’s health services and national plague programme, have conducted the world’s first rigorous clinical trial of treatments for bubonic plague.

New WHO Collaborating Centre for Genomic Surveillance of Antimicrobial Resistance launched

Hosted by the Centre for Genomic Pathogen Surveillance at PSI, the new Centre will support efforts to tackle one of the most pressing global health challenges of our time.

Professor Teresa Lambe OBE shows HRH the Duke of Gloucester around the Tissue Culture Room alongside PhD Student Jack Saunders whose research focuses on Crimean-Congo haemorrhagic fever

HRH The Duke of Gloucester visits University of Oxford’s cutting-edge vaccine facilities

The visit to the Clinical BioManufacturing Facility and the laboratories of the Oxford Vaccine Group and Pandemic Sciences Institute showcased Oxford’s global leadership in medical science and innovation.

Construction begins on state-of-the-art research facility

The University of Oxford held a groundbreaking ceremony on Tuesday 24 June to celebrate the start of construction of the Cyrus Poonawalla Vaccines Research Building. The ceremony marks a significant milestone in Oxford’s mission to counter and constrain global health threats.

Online places still available for the International Pandemic Sciences Conference 2025

Online delegates will gain insights into pandemic preparedness from wherever they are in the world.

Oxford vaccine against deadly Nipah virus granted European Medicines Agency PRIME designation

The designation recognises the vaccine’s potential to address the unmet medical need arising from the devastating Nipah virus disease, which can be fatal in up to 85% of cases.

PSI's Omar El Muhanna awarded Jordanian Order for Distinction

This honour comes in recognition of Mr El Muhanna's outstanding contributions to the field of biomanufacturing and his contributions to international patents.

New research published on maximising mpox vaccine availability

Scientists have studied the immune response of a dose-sparing regimen to expand vaccine supply and protect more people from mpox.

First validated tool to measure stigma during multiple infectious disease outbreaks published

The new RAPID Stigma Scales, led by researchers at the PSI, will help health professionals to monitor stigma in disease outbreak settings, improving outbreak responses globally.

Two new Associate Professorships demonstrate PSI’s impact in research, teaching and practice

The title recognises the researchers’ “significant and sustained academic contribution” to the University.

Portrait of Alice Norton

The new Pandemic Agreement offers a glimmer of hope that no country will face future pandemic threats alone

Professor Alice Norton reflects on what the new Pandemic Agreement means for global health security.

Sarah Gilbert receives Royal Society of Chemistry Honorary Fellowship

PSI Principal Investigator Professor Dame Sarah Gilbert has been made an Honorary Fellow of the Royal Society of Chemistry.

Load More